{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:22:50Z","timestamp":1791901370456,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.jcrc.2005.01.001","type":"journal-article","created":{"date-parts":[[2005,9,6]],"date-time":"2005-09-06T21:19:34Z","timestamp":1126041574000},"page":"155-161","source":"Crossref","is-referenced-by-count":89,"title":["Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system"],"prefix":"10.1016","volume":"20","author":[{"given":"Sean M.","family":"Bagshaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin B.","family":"Laupland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.E.","family":"Boiteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Godinez-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2005.01.001_bib1","first-page":"S125","article-title":"Continuous versus intermittent renal replacement therapy in the intensive care unit","volume":"53","author":"Bellomo","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcrc.2005.01.001_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa010877","article-title":"Daily dialysis and the outcome of acute renal failure","volume":"346","author":"Schiffl","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2005.01.001_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00134-003-1672-8","article-title":"Continuous is not continuous: the incidence and impact of circuit \u201cdowntime\u201d on uraemic control during continuous veno-venous haemofiltration","volume":"29","author":"Uchino","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2005.01.001_bib4","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1097\/00003246-199910000-00026","article-title":"A controlled trial of low-molecular weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration","volume":"27","author":"Reeves","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2005.01.001_bib5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-002-1249-y","article-title":"Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent","volume":"28","author":"Fiaccadori","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2005.01.001_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000420222","article-title":"Nafamostat mesylate as anti-coagulant in continuous hemofiltration and continuous hemodiafiltration","volume":"93","author":"Ohtake","year":"1991","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.jcrc.2005.01.001_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1681\/ASN.V71145","article-title":"Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage","volume":"7","author":"Van De Wetering","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jcrc.2005.01.001_bib8","first-page":"1768","article-title":"Heparin-induced thrombocytopenia during continuous haemofiltration","volume":"10","author":"Samuelsson","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jcrc.2005.01.001_bib9","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1016\/S0272-6386(98)70041-1","article-title":"Management of heparin-induced thrombocytopenia during continuous renal replacement therapy","volume":"32","author":"Davenport","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcrc.2005.01.001_bib10","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1007\/s001340000676","article-title":"Transfusion requirements during continuous veno-venous haemofiltration: the importance of filter life","volume":"26","author":"Cutts","year":"2000","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2005.01.001_bib11","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S0272-6386(97)90538-2","article-title":"The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit","volume":"30","author":"Davenport","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcrc.2005.01.001_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00000441-196107000-00005","article-title":"Regional anticoagulation during hemodialysis using citrate","volume":"242","author":"Morita","year":"1961","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jcrc.2005.01.001_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1056\/NEJM198302033080506","article-title":"Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding","volume":"308","author":"Pinnick","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2005.01.001_bib14","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.1990.300","article-title":"Regional citrate anticoagulation for continuous arterio-venous hemodialysis in critically ill patients","volume":"38","author":"Mehta","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcrc.2005.01.001_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000184287","article-title":"Citrate regional anticoagulation in haemodialysis","volume":"46","author":"Hocken","year":"1987","journal-title":"Nephron"},{"key":"10.1016\/j.jcrc.2005.01.001_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000420221","article-title":"Regional citrate anticoagulation for CAVHD\u2014an update after 12 months","volume":"93","author":"Mehta","year":"1991","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.jcrc.2005.01.001_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1523-1755.1999.00444.x","article-title":"Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding","volume":"55","author":"Palsson","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcrc.2005.01.001_bib18","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0272-6386(00)70248-4","article-title":"Regional citrate anticoagulation in continuous venovenous hemodiafiltration","volume":"35","author":"Kutsogiannis","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcrc.2005.01.001_bib19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1523-1755.2001.00809.x","article-title":"Simplified citrate anticoagulation for continuous renal replacement therapy","volume":"60","author":"Tolwani","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcrc.2005.01.001_bib20","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00134-002-1443-y","article-title":"Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge","volume":"28","author":"Gabutti","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2005.01.001_bib21","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s00134-003-1801-4","article-title":"A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration","volume":"29","author":"Dorval","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2005.01.001_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5414\/CNP59106","article-title":"A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD)","volume":"59","author":"Mitchell","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jcrc.2005.01.001_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.ajkd.2003.09.014","article-title":"Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate","volume":"43","author":"Gupta","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcrc.2005.01.001_bib24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5414\/CNP61134","article-title":"Improving the delivery of continuous renal replacement therapy using citrate anticoagulation","volume":"61","author":"Swartz","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jcrc.2005.01.001_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00134-003-2047-x","article-title":"Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study","volume":"30","author":"Monchi","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2005.01.001_bib26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ki.1996.380","article-title":"Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group","volume":"50","author":"Liano","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcrc.2005.01.001_bib27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/01.CCM.0000108881.14082.10","article-title":"Study of clinical course of organ dysfunction in intensive care","volume":"32","author":"Doig","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2005.01.001_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/jcrc.2003.50006","article-title":"A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions","volume":"18","author":"Tobe","year":"2003","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2005.01.001_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/ndt\/gfg488","article-title":"Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions","volume":"19","author":"Cointault","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jcrc.2005.01.001_bib30","doi-asserted-by":"crossref","first-page":"c131","DOI":"10.1159\/000079171","article-title":"Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience","volume":"97","author":"Morgera","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jcrc.2005.01.001_bib31","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1097\/01.CCM.0000084871.76568.E6","article-title":"Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients","volume":"31","author":"Kramer","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2005.01.001_bib32","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s001340000691","article-title":"Continuous veno-venous hemofiltration without anticoagulation in high-risk patients","volume":"26","author":"Tan","year":"2000","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2005.01.001_bib33","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1503\/cmaj.1040713","article-title":"Responding to tragic error: lessons from Foothills Medical Centre","volume":"170","author":"Johnson","year":"2004","journal-title":"CMAJ"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944105000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944105000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T01:29:10Z","timestamp":1626485350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944105000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0883944105000262"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2005.01.001","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}